Circumferential Endoscopic Mucosal Resection in Barrett’s Esophagus with High-Grade Intraepithelial Neoplasia or Mucosal Cancer. Preliminary Results in 21 Patients

Background and Study Aims: Treatment by endoscopic mucosal resection (EMR) has been established for early lesions in Barrett’s esophagus. However, the remaining Barrett’s esophagus epithelium remains at risk of developing further lesions. The aim of this study was to evaluate the efficacy of circumferential endoscopic mucosectomy (circumferential EMR)s in removing not only the index lesion (high-grade intraepithelial neoplasia (HGIN) or mucosal cancer), but also the remaining Barrett’s esophagus epithelium.

Patients and Methods: A total of 21 patients were included in the study (11 men, 10 women), who had Barrett’s esophagus and either HGIN (n = 12) or mucosal cancer (n = 9). Of the patients, 17/21 were at high surgical risk and five had refused surgery. On the basis of preprocedure endosonography their lesions were classified as T1N0 (n = 19) or T0N0 (n = 2). The lesions and the Barrett’s esophagus epithelium were removed by polypectomy after submucosal injection of 10-15 ml of saline; a double-channel endoscope was used in 15/21 cases. Circumferential EMR was performed in two sessions, the lesion and the surrounding half of the circumferential Barrett’s esophagus mucosa being removed in the first session. In order to prevent the formation of esophageal stenosis, the second half of the Barrett’s esophagus mucosa was resected 1 month later.

Results: Complications occurred in 4/21 patients (19 %), consisting of bleeding which was successfully managed by endoscopic hemostasis in all cases. No strictures were observed during follow-up (mean duration 18 months) and endoscopic resection was considered complete in 18/21 patients (86 %). For three patients, histological examination showed incomplete removal of tumor: one of these underwent surgery; two received chemoradiotherapy, and showed no evidence of residual tumor at 18 months’ and 24 months’ follow-up, respectively. Two patients in whom resection was initially classified as complete later presented with local recurrence and were treated again by EMR. Barrett’s esophagus mucosa was completely replaced by squamous cell epithelium in 15/20 patients (75 %).

Conclusions: Circumferential EMR is a noninvasive treatment of Barrett’s esophagus with HGIN or mucosal cancer, with a low complication rate and good short-term clinical efficacy. Further studies should focus on long-term results and on technical improvements.

References

• 1 Suzuki H, Masuda K, Fujisaki J, Okuwaki S. Endoscopic treatment of gastrointestinal cancers: indication and limitation.  Jpn J Clin Med. 1996;  54 1699-1704
• 2 Matsushita M, Hajiro K, Okazaki K, Takakuwa H. Endoscopic mucosal resection of gastric tumors located in the lesser curvature of the upper third stomach.  Gastrointest Endosc. 1997;  45 512-515
• 3 Takeshita K, Tani M, Inoue H. et al . Endoscopic treatment of early esophageal or gastric cancer.  Gut. 1997;  40 123-127
• 4 Akiyama M, Ota M, Nakajima H. et al . Endoscopic mucosal resection of gastric neoplasms using a ligating device.  Gastrointest Endosc. 1997;  45 182-186
• 5 Tada M, Inoue H, Yabata E. et al . Feasibility of the transparent cap-fitted colonoscope for screening and mucosal resection.  Dis Colon Rectum. 1997;  40 618-621
• 6 Sohendra N, Binmoeller K F, Bohnacker S. et al . Endoscopic snare mucosectomy in the esophagus without any additional equipment: a simple technique of resection of flat early cancer.  Endoscopy. 1997;  29 380-383
• 7 Giovannini M, Bernardini D, Moutardier V. et al . Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients.  Endoscopy. 1999;  31 698-701
• 8 Ell C, May A, Gossner L. et al . Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus.  Gastroenterology. 2000;  118 670-677
• 9 Winters C, Spurling T J, Chobanian S J. et al . Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease.  Gastroenterology. 1987;  92 118-124
• 10 Pratch A T, Macdonald T A, Hopwood D A, Johnston D A. Increasing incidence of Barrett’s esophagus: education, enthusiasm or epidemiology?.  Lancet. 1997;  350 933-943
• 11 Heitmiller R F, Redmond M, Hamilton S R. Barrett’s esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy.  Ann Surg. 1996;  224 66-71
• 12 Nigro J J, Hagen J A, Demeester T R. et al . Occult esophageal adenocarcinoma: extent of disease and implication for effective therapy.  Ann Surg. 1999;  230 433-440
• 13 Katada C, Muto M, Manabe T. et al . Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions.  Gastrointest Endosc. 2003;  57 165-169
• 14 Yamamoto H, Kawata H, Sunada K. et al . Success rate of curative endoscopic mucosal resection with circumferential incision assisted by submucosal injection of sodium hyaluronidate.  Gastrointest Endosc. 2002;  56 507-512
• 15 Kamler J P, Borsatto R, Binmoeller K F. Circumferential endoscopic mucosal resection in the swine esophagus assisted by a cap attachment.  Gastrointest Endosc. 2002;  55 923-928
• 16 Yanai H, Yoshida T, Harada T. et al . Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes.  Gastrointest Endosc. 1996;  44 578-582
• 17 Murata Y, Suzuki S, Ohta M. et al . Small ultrasonic probes for determination of the depth of superficial esophageal cancer.  Gastrointest Endosc. 1996;  44 23-28
• 18 Yanai H, Tada M, Karita M, Okita K. Diagnostic utility of 20-megahertz linear endoscopic ultrasonography in early gastric cancer.  Gastrointest Endosc. 1996;  44 29-33
• 19 Mitomi T, Makuucuhi H. Lymph node dissection for T1 esophageal cancer.  J Jpn Surg Soc. 1997;  98 727-732
• 20 Akahoshi K, Chijiiwa Y, Hamada S. et al . Endoscopic ultrasonography: a promising method for assessing the prospects of endoscopic mucosal resection in early gastric cancer.  Endoscopy. 1997;  29 614-619
• 21 May A, Gossner L, Pech O. et al . Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus: curative treatment using local endoscopic treatment.  Endoscopy. 2002;  34 604-610
• 22 Fujita H, Sueyoshi S, Yamana H. et al . Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.  World J Surg. 2001;  25 424-431
• 23 Schnell T G, Sontag S J, Chejfec G. et al . Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia.  Gastroenterology. 2001;  120 1607-1619
• 24 Buttar N S, Wang K K, Lutzke L S. et al . Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus.  Gastrointest Endosc. 2001;  54 682-688
• 25 Gossner L, Stolte M, Sroka R. et al . Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
• 26 Overholt B f, Panjehpour M, Haydek J M. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients.  Gastrointest Endosc. 1999;  49 1-7
• 27 May A, Gossner L, Gunter E. et al . Local treatment of early cancer in short Barrett’s esophagus by means of argon plasma coagulation: initial experience.  Endoscopy. 1999;  31 1-4